RecruitingNCT03327779
World Bleeding Disorders Registry
Sponsor
World Federation of Hemophilia
Enrollment
20,000 participants
Start Date
Jan 26, 2018
Study Type
OBSERVATIONAL
Conditions
Summary
The WBDR is an international observational disease registry of patients with hemophilia. It will provide a platform for a network of hemophilia treatment centres (HTCs) around the world to collect uniform and standardized patient data and guide clinical practice. With informed consent from the patient, the WBDR stores anonymous data about the person's disease, such as hemophilia type and severity, symptoms, and treatment.
Eligibility
Inclusion Criteria1
- Patients of participating Hemophilia Treatment Centres with Hemophilia A or B, or von Willebrand Disease
Exclusion Criteria1
- none
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03327779
Related Trials
A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
NCT072262062 locations
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
NCT0439862871 locations
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
NCT0637978944 locations
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
NCT0741660412 locations
A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
NCT074165262 locations